Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,912.00
+441.00 (29.98%)
Feb 5, 2026, 2:21 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 25.44 billion as of February 4, 2026. Its market cap has decreased by -49.68% in one year.
Market Cap
25.44B
Enterprise Value
30.59B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,912.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 25.44B, a decrease of -71.80%. That is a compound annual growth rate of -55.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 25.44B | -11.44% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 233.23B |
| Genexine | 229.22B |
| Macrogen | 195.15B |
| ENCell | 190.42B |
| GeneOne Life Science | 163.50B |
| IMB Dx | 128.82B |
| iNtRON Biotechnology | 121.24B |
| Oncocross | 108.77B |